The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Dedicated to enhancing knowledge and skill in the care of the allergic patient."
In a span of 4 days, Congress passed legislation to fund the government through March…
Before the close of 2017, all physicians must take action to avoid the 4 percent…
The Centers for Medicare and Medicaid Services (CMS) released a proposed rule outlining the requirements…
Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA). Read More
CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More
What is it in today’s otolaryngology practice that is resonating as a hot topic? Where are the novel treatment strategies? What is today’s typical otolaryngology practice or more specifically the typical AAOA member’s practice? These are the questions we try to address when building out our Advanced Course in Allergy & Immunology. Read More
CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More
Editor in Chief Search
The ARS-AAOA IFAR LLC is pleased to announce its search for Editor in Chief, term beginning April 2020. Read More
IFAR Impact Factor: 2.135
2018 Advanced Course in Allergy & Immunology
December 6-8 | Atlanta, GA
Learn More and Register
2019 Interactive Allergy & Rhinology Course
February 8-10, 2019 | Dallas, TX
Save the Date
2019 Basic Course in Allergy & Immunology
June 27-29 | Minneapolis, MN
Save the Date
2019 AAOA Annual Meeting
September 13-15 | New Orleans, LA
Save the Date
AAOA Clinical Insights
Learn More and Register
There seem to be more and more medications available for allergy treatment that you can now purchase over the counter.
The FDA is allowing previously prescription only drugs to be made available directly to the consumer without a prescription — adding more to the over-the-counter options in the healthcare aisles.
FOR IMMEDIATE RELEASE Contact: Marina Fassnacht Director of Marketing and Communications 11130 Sunrise Valley Dr.…
Nationwide shortage of Sterile Water for Injections is affecting multiple manufacturers. Some Specialty Pharmacies are…
Building off the success of our radically re-designed Chicago Annual Meeting, we look forward to…
The Food and Drug Administration (FDA) states, in a revised…
The Advocacy Council of the American College of Allergy, Asthma…